Sellwin Share Price Hits Upper Circuit As Board Approves Conversion Of 49.35 Lakh Warrants

Sellwin Traders Limited has made a key announcement that caught the attention of the market. The company informed the exchanges that its Board of Directors has approved the conversion of warrants into equity shares. 

Conversion Of Warrants Into Equity Shares

The Board of Directors approved the conversion of 49.35 lakh warrants into an equal number of equity shares of face value ₹2 each. This conversion was completed pursuant to the rights attached to the warrants, which were earlier issued through a preferential allotment.

Impact On Share Capital

Following this conversion, the issued, subscribed and paid-up equity share capital of the company has increased to ₹46.97 crore. This now comprises 23,48,57,500 fully paid-up equity shares of face value ₹2 each. The newly issued shares will rank equally with the existing equity shares of the company. 

Details Of The Allotment

The equity shares were issued at a price of ₹5.50 each. Out of this, ₹1.375 per share (25% of the consideration) had already been received earlier, while the balance ₹4.125 per share (75% of the consideration) was received upon conversion. The allotment was made to four investors, namely Neelam Dharmesh Patel, Smita Patel, Patel Mitesh and Falgun Anilkumar Yagnik. 

Sellwin Share Price Performance 

This development resulted in Sellwin share price hitting the upper circuit of 2% on September 15, 2025. The stock has jumped by 219% in the last 3 months. 

Read More: KRBL Shares Plunge Over 9% Following Independent Director’s Exit Over Governance Concerns! 

Conclusion 

The Board’s approval of the warrant conversion signals a notable change in Sellwin’s shareholding pattern. This adjustment provides greater clarity on the company’s capital structure and has drawn investor attention in the market.

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities are subject to market risks. Read all related documents carefully before investing.